Form 8K Adial Pharmaceuticals Inc For: 17 August
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Adial Pharmaceuticals Inc (ADIL)
Adial Pharmaceuticals Inc stock price live, this page displays NASDAQ ADIL stock exchange data. View the ADIL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Adial Pharmaceuticals Inc real time stock price chart below.
What Is the Adial Pharmaceuticals Inc Stock Price Today?
The Adial Pharmaceuticals Inc stock price today is 4.000.
What Is the Stock Symbol for Adial Pharmaceuticals Inc?
The stock symbol for Adial Pharmaceuticals Inc is "ADIL."
What Stock Exchange Does Adial Pharmaceuticals Inc Trade On?
Adial Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Adial Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Adial Pharmaceuticals Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ADIL quote. (ISIN: US00688A3041)
What Is the Adial Pharmaceuticals Inc Stock Price Today?
The Adial Pharmaceuticals Inc stock price today is 4.000.
What Is the Stock Symbol for Adial Pharmaceuticals Inc?
The stock symbol for Adial Pharmaceuticals Inc is "ADIL."
What Stock Exchange Does Adial Pharmaceuticals Inc Trade On?
Adial Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Adial Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Adial Pharmaceuticals Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ADIL quote. (ISIN: US00688A3041)
4.000
-0.040(-0.99%)
Real-time Data·
Fair Value
An estimate of a Adial Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.000
4.000
52 wk Range
1.310
10.750
ADIL is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Adial Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.0004.000
52 wk Range
1.31010.750
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ADIL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Adial Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
8.333
Upside
+108.33%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Form 4 Adial Pharmaceuticals Inc For: 16 July- Investing.com
Form 8K Adial Pharmaceuticals Inc For: 13 August- Investing.com
- Form 8K Adial Pharmaceuticals Inc For: 17 August
- Investing.com
- Form 8K Adial Pharmaceuticals Inc For: 13 August
- Investing.com
Form 8K Adial Pharmaceuticals Inc For: 11 August- Investing.com
Adial Pharma receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
3 Buy
1 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 8.333
(+108.33% Upside)
Earnings
Latest Release
Aug 17, 2026
EPS / Forecast
-11.25 / -1.07
Revenue / Forecast
-- / --
Compare ADIL to Peers and Sector
Metrics to compare | ADIL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipADILPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.2x | −3.6x | −0.4x | |
PEG Ratio | −0.01 | −0.22 | 0.00 | |
Price/Book | −0.3x | 2.2x | 2.6x | |
Price / LTM Sales | - | 2.4x | 3.1x | |
Upside (Analyst Target) | 106.3% | 56.8% | 55.6% | |
Fair Value Upside | Unlock | 10.0% | 7.8% | Unlock |
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company’s lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Adial Pharma (ADIL) Stock Price Today?
The Adial Pharma stock price today is 4.000 USD.
What Stock Exchange Does Adial Pharma Trade On?
Adial Pharma is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Adial Pharma?
The stock symbol for Adial Pharma is "ADIL."
What Is the Adial Pharma (ADIL) Afterhours Price Today? (Afterhours variable test: 3.860) Current Date: Sep 24, 2026
After hours price: 3.860. After hours price change (units): -0.180. Price change percentage: -4.460%
What Is the Adial Pharma Market Cap?
As of today, Adial Pharma market cap is 10.610M USD.
What Is Adial Pharma's Earnings Per Share (TTM)?
The Adial Pharma EPS (TTM) is -22.012.
When Is the Next Adial Pharma Earnings Date?
Adial Pharma will release its next earnings report on Nov 18, 2026.
From a Technical Analysis Perspective, Is ADIL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Adial Pharma Stock Split?
Adial Pharma has split 2 times.
How Many Employees Does Adial Pharma Have?
Adial Pharma has 5 employees.
What is the current trading status of Adial Pharma (ADIL)?
As of Sep 24, 2026, Adial Pharma (ADIL) is trading at a price of 4.000 USD, with a previous close of 4.040 USD. The stock has fluctuated within a day range of 4.000 USD to 4.000 USD, while its 52-week range spans from 1.310 USD to 10.750 USD.
What Is Adial Pharma (ADIL) Price Target According to Analysts?
The average 12-month price target for Adial Pharma is 8.333 USD, with a high estimate of 11 USD and a low estimate of 6 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +108.33% Upside potential.
What Is the ADIL Premarket Price?
ADIL's last pre-market stock price is 4.230 USD. The pre-market share volume is 10.000, and the stock has decreased by 0.190, or 4.700%.
What Is the ADIL After Hours Price?
ADIL's last after hours stock price is 3.860 USD, the stock has decreased by -0.180, or -4.460%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.